Real-World Study Looks at Use of Bezlotoxumab, FMT for CDI Real-World Study Looks at Use of Bezlotoxumab, FMT for CDI

A single-center study suggests that FMT and bezlotoxumab ― two recommended therapies for recurrent C difficile infections ― are not commonly used in Spain, which doesn ' t appear to align with US practice.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news